FDA is years behind in its statutory mandate to put graphic warnings on cigarette labels.
Scholar argues that regulators will have difficulty applying cost-benefit analysis to mandatory GMO labeling.
Regulator solicits input on a new rule defining when foods could be considered “healthy.”
Zubik v. Burwell highlights thorny issues surrounding Obamacare’s contraceptive coverage requirement.
Regulatory capture, neither inevitable nor a death trap for agencies, must be reduced to advance public policy goals.
Reviving our regulatory system should be a top priority for the next President.
FDA issues new guidelines to medical device manufacturers to mitigate cybersecurity concerns.
Agenda details some of the Administration's high priority rules for 2016.
The FDA requests information in possible first steps to regulate the term “natural” on food labels.
Researchers argue for reducing FDA involvement in medical device regulation.